期刊文献+

重型血友病A经外周置入中心静脉导管现状分析

Analysis of peripherally inserted central catheters in children with severe hemophilia A
下载PDF
导出
摘要 目的探索和总结经外周静脉置入中心静脉置管(PICC)在重型血友病治疗中的经验。方法回顾性收集2020年1月-2023年12月在首都医科大学附属北京儿童医院接受PICC的重型血友病A儿童的基本信息,电话询问其目前治疗现状及PICC并发症情况。结果共纳入76例重型血友病A患儿,中位年龄4.2(2.3-5.8)岁,共安装123次PICC。安装PICC前,有17.1%(13/76)的患儿开展了家庭治疗;安装后,84.2%(64/76)的患儿进行了家庭治疗。有7.9%(6/76)的患儿出现导管位置改变,10.5%(8/76)出现导管阻塞,39.5%(30/76)出现贴膜下以及贴膜周围皮肤皮疹,2例患儿出现导管相关血栓,5例自行将PICC导管拔除,7例出现导管相关感染。结论重型血友病A患儿PICC置入后,置管局部皮疹、导管堵塞、导管滑脱、导管血栓及导管相关感染等并发症较常发生,应充分考虑多种因素,为其建立最适合的血管通路。 Objective To explore and summarize the real experience of Peripherally Inserted Central Venous Catheters(PICC)in treating children with severe hemophilia.Methods Basic information on children with severe hemophilia A who were treated with PICC at Beijing Children′s Hospital of Capital Medical University from January 2020 to December 2023 was retrospectively collected.The current treatment status of these children and data on PICC-related complications were obtained through telephone interviews and other methods.Results Seventy-six children with severe haemophilia A were enrolled in this study,with a median age of 4.2(2.3,5.8)years.123 PICCs were installed in 76 children,and in 54 children with inhibitors.Before PICC installation,17.1%(13/76)of the children were treated at home.After PICC installation,84.2%(64/76)of the children underwent home treatment.7.9%(6/76)of the children had a change in catheter position,10.5%(8/76)had catheter obstruction,39.5%(30/76)had a rash of the skin under the patch and around the patch,2 children had catheter-related thrombosis,5 children removed the PICC on their own,and 7 children removed the catheter on their own.Catheters were removed in 5 children,and 7 children developed catheter-related infections.Conclusions PICC placement is a practical and safe option for children with severe haemophilia A with inhibitors during ITI treatment.However,there are still deficiencies in PICC placement,such as complications such as local rash,catheter blockage,catheter slippage,catheter thrombosis and catheter-related infections still occur more frequently.The most suitable vascular access should be established for individual children with severe haemophilia.
作者 甄英姿 陈振萍 刘国青 王春立 艾迪 吴心怡 迟巍 吴润晖 ZHEN Yingzi;CHEN Zhenping;LIU Guoqing;WANG Chunli;AI Di;WU Xinyi;CHI Wei;WU Runhui(Nursing Department,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health;Department of Clinical Laboratory Center,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health;Hematology Department,Beijing Children′s Hospital,Capital Medical University,National Center for Children′s Health)
出处 《中国小儿血液与肿瘤杂志》 CAS 2024年第4期264-268,共5页 Journal of China Pediatric Blood and Cancer
基金 医管局培育项目(PX2024043)。
关键词 血友病 儿童 经外周静脉穿刺中心静脉置管 并发症 家庭治疗 Haemophilia Children Peripherally Inserted Central Venous Catheters Complications Home treatment
  • 相关文献

参考文献2

二级参考文献25

  • 1Astermark J, Berntorp E, White GC, et al. The MalmO International Brother Study (MIBS) : further support for genetic predisposition to inhibitor development in hemophilia patients. Hemophilia, 2001,7: 267 -272.
  • 2Hay CR, Palmer B, Chalmers E, et al. Incidence of factor V inhibitors throughout life in severe hemophilia in the United Kingdom. Blood, 2011, 117 : 6367-6370.
  • 3Gouw SC, van den Berg HM, Oldenburg J, et al. F8 gene mutation type and inhibitor development in patients with severe hemophilia A : systematic review and meta-analysis. Blood, 2012, 119: 2922-2934.
  • 4Bardi E, Astermark J, Genetic risk factors for inhihitors in haemophilia A. Eur J Haematol, 2015, 94 Suppl 77 : 7-10.
  • 5Astermark J. F VI inhibitors: pathogenesis and avoidance. Blood, 2015,125 : 2045-2051.
  • 6Astermark J. Why do inhibitors develop.'? Principles of and factors influencing the risk for inhibitor development in haemophilia. Haemophilia, 2006, 12 Suppl 3 : 52-60.
  • 7Eckhardt CL, van der Bom JG, van der Naald M. Surgery and inhibitor development in hemophilia A: a systematic review. J Thromb Haemost, 2011,9 : 1948-1958.
  • 8Gouw SC1, van der Bom JG, Marijke van den Berg H. Treatment- related risk factors of inhibitor development in previously untreated patients with hemophilia A : the CANAL cohort study. Blood, 2007, 109 : 4648-4654.
  • 9Auerswald G, Kumik K, Aledort LM, et al. The EPIC study: a lesson to learn. Haemophilia, 2015, 21: 622-628.
  • 10Schwaab R, Oldenburg J, Schwaab U, et al. Characterization of mutations within the factor V gene of 73 unrelated mild and moderate haemophiliacs. Br J Haematol, 1995, 91 : 458-464.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部